Cell Expansion Market Share, Size, Growth Drivers, 2028

Cell Expansion Market: Industry Perspective

The global cell expansion market size was worth around USD 15292.5 million in 2021 and is predicted to grow to around USD 35004.9 million by 2028 with a compound annual growth rate (CAGR) of roughly 14.8% between 2022 and 2028.

The report analyzes the global cell expansion market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cell expansion industry.

Request Free Sample

Cell Expansion Market: Overview

Cell expansion is a process wherein daughter cell production is done from a single cell in an artificial environment by using culture media and other supplements required for growth. The whole process for the production of daughter cells is carried out in the bioreactor on a large scale. These daughter cells are used for various purposes in the healthcare industry which involves increased usage of regenerative medicines and various other clinical trials. The use of these bioreactors on a large scale is very useful and it reduces labor and manpower and also reduces the cleaning process on a large scale. The process of cell expansion is mostly used in the development of new drugs, research, and others. It is also widely used for the improved transplantation and treatment of various diseases such as diabetes, arthritis, and others.

The cell expansion market is expected to see a substantial increase in demand as the focus on cell therapies bolsters with rising research and development for the same. The cell expansion market will also be driven by rising investments in the healthcare and pharmaceutical industries to bolster offerings provided by multiple firms operating in the cell expansion market landscape.

Rising research in cell technology, growing demand for personalized medicine, rising focus on healthcare, growing geriatric population, developing healthcare infrastructure, increasing prevalence of chronic diseases, etc. are some major factors that propel cell expansion market potential.

Request Free Sample

Cell Expansion Market: Growth Drivers

Cell Expansion market Increasing Prevalence of Chronic Ailments

Cancer and other chronic diseases have increased in prevalence in recent years and this has bolstered the demand for cell-based therapies and thus propelled the research in the cell expansion market. Increasing research will eventually lead to new launches and these are expected to further bolster the cell expansion market growth trend through 2028 and lead the market growth in the changing healthcare landscape.

One of the major factors driving the growth of the cell expansion market is the increased use of regenerative medicine and chronic medical conditions. To treat those medical conditions and study the effect of developed medicines in the cells has increased the demand for cell expansion. Increased awareness among the people regarding stem cells and their uses has also increased the demand for stem cell preservation which is further expected to drive the growth of the cell expansion market over the forecast period.

Furthermore, development in the research and development activities coupled with various technological advancements for cell expansion is expected to fuel the growth of the cell expansion market over the forecast period. However, the high cost involved in the operation with skilled labor and stringent government regulations for the cell expansion process due to ethical issues are factors expected to hamper the growth of the cell expansion market shortly.

Cell Expansion Market: Restraints

Rising Concerns About Use of Humans and Animals for Cell Research

The cell expansion market is incomplete without cell research and this trend is expected to be the major driver as well as a major restraint to the market due to the ethical concerns associated with it. The use of humans and animals for research has had some pushback from activists across the world and has resulted in slowed research and development activity which constrains the market from attaining full growth. This factor is being worked on to address and change the cell research approach to be more safe and compliant with human and animal rights.

Cell Expansion Market: Segmentation

The global cell expansion market is segmented based on product, end-user, application, and region.

By End-user, the market is divided into research institutes, pharmaceutical & biotechnology companies, and others. The Biotechnology & biopharmaceutical companies are anticipated to hold a bright outlook over the forecast period and are anticipated to emerge as a major growth driver for the cell expansion market through 2028. The increasing scope of application for healthcare research is anticipated to majorly boost growth in this segment.

By Application, the cell expansion market is segmented into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. The regenerative medicine segment is expected to have a highly lucrative growth over the forecast period and is expected to be a significant segment over the forecast period. The stem cell technology segment is also anticipated to rise at a fast CAGR through 2028.

Cell Expansion Market: Report Scope

Global Cell Expansion Market: Regional Landscape

North America region leads the global cell expansion market in terms of revenue and volume share and is anticipated to maintain a dominant stance through the forecast period. Increasing focus on healthcare and rising research activities in this region are expected to propel market potential in this region. Increasing awareness about novel treatments, the growing prevalence of the geriatric population, the presence of key cell expansion companies, etc. are some major factors that drive the cell expansion market growth through 2028. The United States is expected to be the most important market in this region over the forecast period.

The market for cell expansion in the Asia Pacific is anticipated to rise at the fastest CAGR over the forecast period. Increasing focus on healthcare is predicted to be a major trend propelling growth in this region. India and China are expected to be the most prominent markets in this region over the forecast period. The increasing geriatric population in Japan is also expected to boost the cell expansion market in this nation.

Recent Developments

• In October 2020 – Danaher a leading name in the healthcare industry announced that it has completed the acquisition of a biopharma business from General Electric Company's Life Sciences division. The acquired venture will function under the name ofCytiva and will be under Danaher’s life sciences segmentation.

Cell Expansion Market: Competitive Landscape

Some of the main competitors dominating the global cell expansion market include -

• Becton, Dickinson and Company
• CorningIncorporated
• Eppendorf
• Sartorius AG
• Merck KGaA
• Lonza Group AG
• PromoCell GmbH
• Danaher Corporation
• Thermo Fisher Scientific
• HiMedia Laboratories

The global cell expansion market is segmented as follows:

By Product

• Consumables
• Instruments

By End-User

• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Application

• Stem Cell Technology
• Cancer Research
• Drug Screening & Development
• Tissue Engineering & Regenerative Medicine
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa